Compound Summary
chlorzoxazone
Compound Information
chlorzoxazone
Compound Name: | chlorzoxazone |
Compound CID: | 2733 |
Synonyms: | chlorzoxazone 95-25-0 Paraflex Chloroxazone Chlorzoxazon More... |
Iupac Name: | 5-chloro-3H-1,3-benzoxazol-2-one |
InChI: | InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10) |
InChIKey: | TZFWDZFKRBELIQ-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC2=C(C=C1Cl)NC(=O)O2 |
Isomeric Smiles: | C1=CC2=C(C=C1Cl)NC(=O)O2 |
Molecular Weight: | 169.56 |
Molecular Formula: | C7H4ClNO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
chlorzoxazone
Molecular Weight: | 169.56 |
Molecular Formula: | C7H4ClNO2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 11 |
Complexity: | 185 |
Synonyms
chlorzoxazone
| chlorzoxazone | chlorzoxazone |
|---|---|
chlorzoxazone |
95-25-0 |
Paraflex |
Chloroxazone |
Chlorzoxazon |
5-Chloro-2-benzoxazolone |
2(3H)-Benzoxazolone, 5-chloro- |
Biomioran |
Escoflex |
Myoflexin |
Myoflexine |
Pathorysin |
5-Chloro-2-hydroxybenzoxazole |
Mioran |
Miotran |
Neoflex |
Solaxin |
5-Chloro-2-benzoxazolinone |
Parafon Forte DSC |
5-Chlorobenzoxazolidone |
5-Chloro-2(3H)-benzoxazolone |
Chlorzoxane |
5-Chlorobenzodoxazol-2(3H)-one |
5-Chloro-1,3-benzoxazol-2(3H)-one |
5-Chloro-2-benzoxazolol |
Usaf ma-10 |
5-Chlorobenzoxazol-2-one |
5-chloro-3H-1,3-benzoxazol-2-one |
Strifon Forte Dsc |
5-Chlorobenzoxazolone |
2-Hydroxy-5-chlorobenzoxazole |
Chlorzoxazonum |
5-Chlorbenzoxazolin-2-on |
5-Chloro-3(H)-2-benzoxazolone |
5-chlorobenzodoxazol-2-ol |
5-Chlorobenzoksazolon-2 |
5-Chlorobenzoksazolinon-2 |
5-chlorobenzoxazolin-2-one |
UNII-H0DE420U8G |
NSC 26189 |
2-BENZOXAZOLINONE, 5-CHLORO- |
5-chloro-3H-benzooxazol-2-one |
5-chloro-1,3-benzoxazol-2-ol |
MFCD00005717 |
CHEMBL1371 |
MLS000069380 |
CHEBI:3655 |
H0DE420U8G |
Chlorsoxazone |
Klorzoxazon |
Nyoflex |
Parafon |
Remofleks |
5-chloro-2,3-dihydro-1,3-benzoxazol-2-one |
Parafon Forte |
Chlorzoxazone-D3 |
NSC-26189 |
CAS-95-25-0 |
NCGC00015238-02 |
Clorzoxazona |
Lorzone |
SMR000058269 |
DSSTox_CID_2813 |
DSSTox_RID_76739 |
DSSTox_GSID_22813 |
CLW |
Chlorzoxazonum INN-Latin |
Clorzoxazona INN-Spanish |
chlorzoxazona |
5-chloro-3-hydrobenzoxazol-2-one |
5-Chlorobenzoksazolon-2 Polish |
5-Chlorobenzoksazolinon-2 Polish |
Paraflex (TN) |
SR-01000075207 |
EINECS 202-403-9 |
component of Parafon Forte |
Strifon |
AI3-63119 |
Chlorzoxazone (JAN/USP/INN) |
Prestwick_62 |
Chlorzoxazone,(S) |
Chlorzoxazone USP:INN:BAN:JAN |
1173023-63-6 |
5-Chlorobenzoxazolinone |
Spectrum_000148 |
Opera_ID_1659 |
Prestwick0_000163 |
Prestwick1_000163 |
Prestwick2_000163 |
Prestwick3_000163 |
Spectrum2_001149 |
Spectrum3_000350 |
Spectrum4_000287 |
Spectrum5_000745 |
Lopac-C-4397 |
C 4397 |
5-Chloro-benzooxazol-2-ol |
5-chloro-benzoxazolin-2-one |
Lopac0_000253 |
SCHEMBL35177 |
BSPBio_000025 |
BSPBio_002019 |
KBioGR_000814 |
KBioSS_000628 |
WLN: T56 BMVOJ HG |
DivK1c_000895 |
SPECTRUM1500188 |
SPBio_001077 |
SPBio_001946 |
BPBio1_000029 |
GTPL2322 |
DTXSID9022813 |
HMS502M17 |
KBio1_000895 |
KBio2_000628 |
KBio2_003196 |
KBio2_005764 |
KBio3_001239 |
NINDS_000895 |
Chlorzoxazone-13C,15N,18O |
HMS1568B07 |
HMS1920O07 |
HMS2091E14 |
HMS2095B07 |
HMS2235I19 |
HMS3259I15 |
HMS3260D08 |
HMS3373P17 |
HMS3652K22 |
HMS3712B07 |
HMS3885N07 |
Pharmakon1600-01500188 |
5-Chloro-2-hydroxybenzodoxazole |
ACT08248 |
ALBB-012641 |
BCP07916 |
HY-B1462 |
NSC26189 |
STR00805 |
Tox21_110105 |
Tox21_500253 |
BBL003952 |
BDBM50290811 |
CCG-40323 |
NSC756693 |
s4155 |
SBB003864 |
STK071582 |
ZINC84843283 |
AKOS000404381 |
Tox21_110105_1 |
component of Parafon Forte (Salt/Mix) |
CS-5155 |
DB00356 |
HG-0202 |
LP00253 |
MCULE-3638156868 |
NC00499 |
NSC-756693 |
SDCCGSBI-0050241.P005 |
5-chloranyl-3H-1,3-benzoxazol-2-one |
5-chloro-1,3-benzoxazole-2(3H)-one |
IDI1_000895 |
Chlorzoxazone 1.0 mg/ml in Acetonitrile |
NCGC00015238-01 |
NCGC00015238-03 |
NCGC00015238-04 |
NCGC00015238-05 |
NCGC00015238-06 |
NCGC00015238-07 |
NCGC00015238-08 |
NCGC00015238-09 |
NCGC00015238-10 |
NCGC00015238-13 |
NCGC00015238-24 |
NCGC00093714-01 |
NCGC00093714-02 |
NCGC00093714-03 |
NCGC00093714-04 |
NCGC00260938-01 |
5-Chloro-1,3-benzoxazol-2(3H)-one # |
AC-12192 |
BP-11613 |
meso-Butane-1,2,3,4-tetracarboxylicAcid |
SBI-0050241.P004 |
AB0011060 |
DB-057571 |
AB00051947 |
EU-0100253 |
FT-0620220 |
ST45024437 |
SW196377-3 |
EN300-31026 |
A16449 |
C07931 |
D00771 |
D78096 |
AB00051947_05 |
AB00051947_06 |
A845253 |
Q3294630 |
SR-01000075207-1 |
SR-01000075207-3 |
SR-01000075207-5 |
W-100168 |
BRD-K98174813-001-05-7 |
BRD-K98174813-001-08-1 |
Z57183224 |
Chlorzoxazone, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
chlorzoxazone
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -10.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
chlorzoxazone
Statistics Data
chlorzoxazone
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -10.000000000000000 | 1 | 1 |
Statistics Data Visualization
chlorzoxazone
